The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 09, 2014

Filed:

Oct. 05, 2011
Applicants:

Paul Allen Sutton, Parsippany, NJ (US);

Michael J. Girgis, Montville, NJ (US);

Jessica Liang, Annandale, NJ (US);

Mahavir Prashad, Montville, NJ (US);

Edwin Bernard Villhauer, Morristown, NJ (US);

Inventors:

Paul Allen Sutton, Parsippany, NJ (US);

Michael J. Girgis, Montville, NJ (US);

Jessica Liang, Annandale, NJ (US);

Mahavir Prashad, Montville, NJ (US);

Edwin Bernard Villhauer, Morristown, NJ (US);

Assignee:

Novartis AG, Basel, CH;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 213/04 (2006.01); A61K 31/44 (2006.01); A61K 31/444 (2006.01); C07D 213/72 (2006.01); A61K 45/06 (2006.01); C07D 401/12 (2006.01);
U.S. Cl.
CPC ...
C07D 213/72 (2013.01); A61K 31/444 (2013.01); A61K 45/06 (2013.01); C07D 401/12 (2013.01);
Abstract

The present invention relates to novel crystalline forms of (4-{4-[5-(6-Trifluoromethyl-pyridin-3-ylamino)-pyridin-2-yl]-phenyl}-cyclohexyl)-acetic acid, sodium and their use in the treatment or prevention of a condition or a disorder associated with DGAT1 activity in animals, particularly humans. It also relates to processes for making such novel crystalline forms.


Find Patent Forward Citations

Loading…